BioNTech
Shulamit Shaakov, MS, US RAC, currently serves as Associate Director of Global Regulatory Affairs CMC Authoring at BioNTech SE since August 2023. Prior experience includes Senior Manager of Regulatory Affairs at Baxter International Inc. from September 2019 to August 2023 and Regulatory Affairs CMC Manager at Astellas Pharma from May 2017 to August 2019. Earlier roles encompass Regulatory Affairs Manager at Momenta Pharmaceuticals and Global Regulatory Affairs Submission Management at Takeda, where responsibilities included leading product-specific regulatory strategy and managing submission teams. Shulamit's career began as a Sr. Analytical Scientist in R&D at Abbott/AbbVie from November 2004 to July 2014, involving the development of analytical test methods and regulatory support. Shulamit holds a Master of Science and a Bachelor of Science in Chemistry from The Hebrew University of Jerusalem.
This person is not in any teams
This person is not in any offices
BioNTech
32 followers
BioNTech was founded in 2008 on the understanding that every cancer patient’s treatment should be individualized. Their vision is to provide patient-specific immunotherapies worldwide.